Brief: Scibase Receives Initial Order For Clinical Study From Castle Biosciences
23/09/2025 07:05
Sept 23 (Reuters) - SciBase Holding AB (publ) SCIB.ST: RECEIVES INITIAL ORDER FOR CLINICAL STUDY FROM CASTLE BIOSCIENCES ORDER CONSISTS OF NEVISENSE GO AND ELECTRODES TO VALUE OF AROUND $0.8 MILLION OR APPROXIMATELY MSEK 8 (ADDS DROPPED WORDS) Source text: [ID:] Further company coverage: SCIB.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))